Does Dr. MOHAMMED ALZOUBAIDI have financial conflicts of interest?

Dr. MOHAMMED ALZOUBAIDI (MBBS,MPH) has received a total of $2,228 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $2,228 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MOHAMMED ALZOUBAIDI?

According to CMS Open Payments data, Dr. MOHAMMED ALZOUBAIDI received funding from PHILIPS ELECTRONICS NORTH AMERICA CORPORATION ($1,786), BOSTON SCIENTIFIC CORPORATION ($413), and REGENERON HEALTHCARE SOLUTIONS ($16).

Does Dr. MOHAMMED ALZOUBAIDI receive research grants or speaking fees?

Dr. MOHAMMED ALZOUBAIDI has received $2,228 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MOHAMMED ALZOUBAIDI

MBBS,MPHReal-Time Hydrated

Specialty: Internal Medicine, Pulmonary Disease

Practice Location: LAKE FOREST, IL 60045

NPI Number: 1184880031

LIFETIME INDUSTRY VALUE

$2,228

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ALZOUBAIDI is a verified Internal Medicine, Pulmonary Disease practitioner based in LAKE FOREST, IL.

Between 2021 and 2024, Dr. ALZOUBAIDI had an overall industry promotional and research financial footprint of $2,228 as recorded in the federal CMS Open Payments database.

$2,228 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ALZOUBAIDI's primary funding source is PHILIPS ELECTRONICS NORTH AMERICA CORPORATION, which accounts for $1,786 (representing 80.1% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

PHILIPS ELECTRONICS NORTH AMERICA CORPORATION

Rank 1

$1,786

80.1%

BOSTON SCIENTIFIC CORPORATION

Rank 2

$413

18.5%

REGENERON HEALTHCARE SOLUTIONS

Rank 3

$16

0.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.